Citation Tools

COMPARISON OF RECURRENCE AND SURVIVALIN PATIENTS WITH ADVANCED EPITHELIAL OVARIAN CANCER TREATED WITH PACLITAXEL AND CISPLATIN VERSUS CISPLATIN/CYCLOPHOSPHAMIDE AS A FIRST LINE CHEMOTHERAPY

Download to a citation manager

Cite this article as:
Majdak E, Debniak J, Kobierski J, et al
COMPARISON OF RECURRENCE AND SURVIVALIN PATIENTS WITH ADVANCED EPITHELIAL OVARIAN CANCER TREATED WITH PACLITAXEL AND CISPLATIN VERSUS CISPLATIN/CYCLOPHOSPHAMIDE AS A FIRST LINE CHEMOTHERAPY